Literature DB >> 9218755

Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes.

D I Godfrey1, S J Kinder, P Silvera, A G Baxter.   

Abstract

As a result of failed induction of T cell tolerance to pancreatic B cells, non-obese diabetic (NOD) mice develop spontaneous autoimmune insulin-dependent diabetes mellitus (IDDM). The thymic stroma, which plays a crucial role in thymic T cell maturation, undergoes extensive premature disorganization in NOD mice, so it is of interest to examine NOD T cell development. In this study, both major and minor developmental populations of thymocytes of NOD/Lt mice were studied and compared to those of BALB/c, C57BL/6 and CBA mice by multiparameter flow cytometry (FACS). These results are described in detail and reveal that most thymocyte subsets were normally represented, including alphaTcR-CD4-CD8- (triple negative; TN), alphabetaTcR-CD4+CD8- and alphabetaTcR-CD4-CD8+ (immature single positive; ISP), alphabetaTcR-/lowCD4+CD8+ (double positive; DP) and alphabetaTcR+CD4+CD8- and alphabetaTcR+CD4-CD8+ (mature single positive; SP) as well as gammadelta T cells. However, NOD mice exhibited a marked deficiency of thymic alphabetaTcR+CD4-CD8- (alphabeta+DN) T cells. alphabeta+DN T cells, which are included among NK1+ T cells in C57BL/6 mice, produce large amounts of IL-4 on primary stimulation. Given the potential significance of NKT cells in immunoregulation, it is possible that the scarcity of these cells in NOD mice plays a role in the pathogenesis of IDDM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218755     DOI: 10.1006/jaut.1997.0129

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  27 in total

Review 1.  The cells that knew too much.

Authors:  A G Baxter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Authors:  Idil Aktan; Alan Chant; Zachary D Borg; David E Damby; Paige C Leenstra; Graham W J Lilley; Graham W G Lilley; Joseph Petty; Benjamin T Suratt; Cory Teuscher; Edward K Wakeland; Matthew E Poynter; Jonathan E Boyson
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 3.  Immunologic states of autoimmune diseases.

Authors:  Toru Abo; Toshihiko Kawamura; Hisami Watanabe
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 5.  The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Authors:  S L Cardell
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 6.  Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.

Authors:  Philomena Arrenberg; Ramesh Halder; Vipin Kumar
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

7.  Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss.

Authors:  Jonathan E Boyson; Nisha Nagarkatti; Leena Nizam; Mark A Exley; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

Review 8.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state.

Authors:  Ghazal Zekavat; Raha Mozaffari; Vanessa J Arias; Susan Y Rostami; Armen Badkerhanian; Andrea J Tenner; Kim E Nichols; Ali Naji; Hooman Noorchashm
Journal:  Immunogenetics       Date:  2010-04-13       Impact factor: 2.846

10.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.